Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Insider selling
View:
Post by Craigbad on Nov 07, 2016 6:12pm

Insider selling

Let this be a lesson to even the most hopeful longs. When insiders sell during an earnings blackout and they only get caught doing it by the safeguard of marker trades, sell your position, no questions asked. When they do it at 52 week lows, a delist and bk protection isnt far off on the horizon. The downtrend is far from over here.
Comment by marlander on Nov 07, 2016 6:45pm
Should find out next week if insider selling was margin call?  New CEO starts tomorrow - maybe find out new plan for company going forward
Comment by marlander on Nov 07, 2016 6:46pm
Should find out next week if insider selling was margin call? @New CEO starts tomorrow - maybe find out new plan for company going forward
Comment by DanKwong1958 on Nov 07, 2016 7:13pm
Yah right.  DOn't hold your breath for the rest of the year.  Did you listen to how the management struggled with answering questions on theat conference call?  The silence between when the question was asked and when someone tried to answer was deafening.  This company couldn't even answer simple revenue questions on their drug portfolio.  No clue.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse